Bio-Rad Laboratories, Inc.
BIOMedical Devices
$384.40−0.19%As of Oct 29vs prior close
- Market cap
- $10.3B
- P/E (TTM)
- 46.6×
- P/E (FY1)
- 40.7×
- From 52W high
- −1.52%
- EPS (LTM)
- $8.19
- Revenue (LTM)
- $2.6B
- Net margin
- 8.59%
- Dividend yield
- 0.00%
Nomior Score
55
Steady ProfileTop 39% of the scored universe
Growth24
Quality64
Value46
Momentum69
Resilience64
Growth
+2.50%revenue a year over 9 fiscal years
FY16 $2.1BLTM $2.6B
Connections
Revenue to profitQ2 FY26
57% of revenue became net profit, up 8 pts on a year.
Who owns it
2funds, 3 tracked portfolios